DiaGenic ASA

DiaGenic is an innovative Norwegian diagnostics company dedicated to the early detection of diseases through the development of innovative and patient-friendly in vitro diagnostic (IVD) products, creating value for patients, partners, and investors. The company’s proprietary concept indicates that a disease triggers a systemic response in the blood specific to that disease, which can be measured using blood samples. DiaGenic is a world leader in identifying gene expression signatures in blood and is committed to developing IVD biomarker products in the field of Alzheimer’s disease. The company protects its technology with an extensive patent portfolio.